imiquimod has been researched along with acyclovir in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL | 1 |
Drehs, MM; Gilbert, J; Weinberg, JM | 1 |
Snoeck, R | 1 |
Germain, M; Skelton, H; Smith, KJ; Yeager, J | 1 |
Brummitt, CF | 1 |
Abdel-Haq, N; Al-Tatari, H; Asmar, B; Chearskul, P | 1 |
Abbo, L; Dickinson, G; Doblecki, S; Haslett, PA; Shrestha, N; Vincek, V | 1 |
Nisbet, M; Perkins, N; Thomas, M | 1 |
Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G | 1 |
Browne, R; McKendry, A; Narayana, S | 1 |
Bechtel, MA; Trout, W | 1 |
Chirachanakul, P; Jiamton, S; Leeyaphan, C; Omcharoen, V; Prasertworonun, N; Punyaratabandhu, P; Surawan, TM | 1 |
Sharma, DP; Singh, J; Sinha, S; Tandon, S | 1 |
Bulai Livideanu, C; Casassa, EA; Fortenfant, F; Gaudin, C; Konstantinou, MP; Lamant, L; Mengelle, C; Nicol, P; Paul, C; Viraben, R | 1 |
Bouscarat, F; Boutolleau, D; Bucau, M; Burrel, S; Fidouh, N; Ghosn, J; Hachon, L; Joly, V; Khellaf, L; Lariven, S; Le Pluart, D; Thy, M | 1 |
4 review(s) available for imiquimod and acyclovir
Article | Year |
---|---|
[Perspectives for the treatment and prevention of herpes simplex infections].
Topics: 2-Aminopurine; Acyclovir; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Simplex Virus Vaccines; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imiquimod; Interferon Inducers; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 2002 |
New antiviral agents.
Topics: 2-Aminopurine; Acyclovir; Aminoquinolines; Antiviral Agents; Bromodeoxyuridine; Famciclovir; Fatty Alcohols; Ganciclovir; Guanine; Humans; Imiquimod; Valganciclovir; Virus Diseases | 2006 |
Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Female; Herpes Genitalis; Humans; Imiquimod; Immunocompromised Host; Male; Middle Aged | 2011 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
13 other study(ies) available for imiquimod and acyclovir
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
Topics: Acute Disease; Acyclovir; Aminoquinolines; Animals; Drug Synergism; Drug Therapy, Combination; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Inducers; Recurrence; Spinal Cord; Vagina; Virus Shedding | 1993 |
Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Humans; Imiquimod; Male; Treatment Failure | 2001 |
Topical 5% imiquimod for the therapy of actinic cheilitis.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Cheilitis; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Stomatitis, Herpetic; Valacyclovir; Valine | 2002 |
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine | 2006 |
Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Dendritic Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Imiquimod; Interferon Inducers; Male | 2007 |
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine | 2012 |
Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
Topics: Acyclovir; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Herpes Simplex; HIV Infections; HIV-1; HIV-2; Humans; Imiquimod; Male; Polymerase Chain Reaction; Simplexvirus; Treatment Outcome; Ulcer | 2015 |
Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ulcer | 2015 |
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine | 2017 |
[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Female; Foscarnet; Herpes Simplex; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Perineum | 2018 |
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Genitalia; Herpes Simplex; Herpesvirus 2, Human; Humans; Imiquimod; Mutation; Obesity; Thymidine Kinase; Valacyclovir | 2022 |